Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

被引：313
|
作者：
Powles, T. [1 ]
Bellmunt, J. [2 ]
Comperat, E. [3 ]
De Santis, M. [4 ]
Huddart, R. [5 ]
Loriot, Y. [6 ,7 ]
Necchi, A. [8 ]
Valderrama, B. P. [9 ]
Ravaud, A. [10 ,11 ]
Shariat, S. F. [12 ]
Szabados, B. [1 ,13 ]
van der Heijden, M. S. [14 ]
Gillessen, S. [15 ]
机构：
[1] Queen Mary Univ London, Barts Canc Ctr, Barts Hlth NHS Trust, London, England
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, IMIM Lab, Boston, MA 02115 USA
[3] Hop Tenon, Assistance Publ Hop Paris, Paris, France
[4] Charite, Dept Urol, Berlin, Germany
[5] Royal Marsden Hosp, Inst Canc Res, London, England
[6] Univ Paris Saclay, Dept Med Oncol, Villejuif, France
[7] Gustave Roussy, Villejuif, France
[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Dept Med Oncol, Milan, Italy
[9] Univ Hosp Virgen del Rocio, Seville, Spain
[10] Hop St Andre CHU, Bordeaux, France
[11] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France
[12] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Vienna, Austria
[13] Univ Coll London Hosp, Dept Urol, London, England
[14] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[15] EOC, Oncol Inst Southern Switzerland IOSI, Lugano, Switzerland
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 03期
关键词：
immune checkpoint inhibitors; fibroblast growth factor receptor inhibitors; antibody drug conjugates; bladder cancer; urothelial carcinoma; platinum-based chemotherapy; METASTATIC UROTHELIAL CARCINOMA; BACILLUS-CALMETTE-GUERIN; PHASE-III TRIAL; TRANSITIONAL-CELL CARCINOMA; COMBINED-MODALITY TREATMENT; RADICAL CYSTECTOMY; OPEN-LABEL; SINGLE-ARM; ADJUVANT CHEMOTHERAPY; PREDICTING RECURRENCE;
D O I：
10.1016/j.annonc.2021.11.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：244 / 258
页数：15
相关论文
共 50 条
  • [1] Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Pham, F. Y. -V.
    Jacquet, E.
    Monard, A.
    Brunel, L.
    Blay, J. -Y.
    Albin, N.
    ANNALS OF ONCOLOGY, 2022, 33 (05) : 561 - 563
  • [2] Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Oaknin, A.
    Bosse, T. J.
    Creutzberg, C. L.
    Giornelli, G.
    Harter, P.
    Joly, F.
    Lorusso, D.
    Marth, C.
    Makker, V
    Mirza, M. R.
    Ledermann, J. A.
    Colombo, N.
    ANNALS OF ONCOLOGY, 2022, 33 (09) : 860 - 877
  • [3] Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Lordick, F.
    Carneiro, F.
    Cascinu, S.
    Fleitas, T.
    Haustermans, K.
    Piessen, G.
    Vogel, A.
    Smyth, E. C.
    ESMO Guidelines Committee
    ANNALS OF ONCOLOGY, 2022, 33 (10) : 1005 - 1020
  • [4] Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Obermannova, R.
    Alsina, M.
    Cervantes, A.
    Leong, T.
    Lordick, F.
    Nilsson, M.
    van Grieken, N. C. T.
    Vogel, A.
    Smyth, E. C.
    ANNALS OF ONCOLOGY, 2022, 33 (10) : 992 - 1004
  • [5] Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Bellmunt, J.
    Orsola, A.
    Wiegel, T.
    Guix, M.
    De Santis, M.
    Kataja, V.
    ANNALS OF ONCOLOGY, 2011, 22 : vi45 - vi49
  • [6] Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up*
    Kraemer, A.
    Bochtler, T.
    Pauli, C.
    Baciarello, G.
    Delorme, S.
    Hemminki, K.
    Mileshkin, L.
    Moch, H.
    Oien, K.
    Olivier, T.
    Patrikidou, A.
    Wasan, H.
    Zarkavelis, G.
    Pentheroudakis, G.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2023, 34 (03) : 228 - 246
  • [7] Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Vogel, A.
    Bridgewater, J.
    Edeline, J.
    Kelley, R. K.
    Klumpen, H. J.
    Malka, D.
    Primrose, J. N.
    Rimassa, L.
    Stenzinger, A.
    Valle, J. W.
    Ducreux, M.
    ANNALS OF ONCOLOGY, 2023, 34 (02) : 127 - 140
  • [8] Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Cervantes, A.
    Adam, R.
    Rosello, S.
    Arnold, D.
    Normanno, N.
    Taieb, J.
    Seligmann, J.
    De Baere, T.
    Osterlund, P.
    Yoshino, T.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2023, 34 (01) : 10 - 32
  • [9] Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
    Bellmunt, J.
    Orsola, A.
    Leow, J. J.
    Wiegel, T.
    De Santis, M.
    Horwich, A.
    ANNALS OF ONCOLOGY, 2014, 25 : 40 - 48
  • [10] Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
    Bellmunt, J.
    Orsola, A.
    Maldonado, X.
    Kataja, V.
    ANNALS OF ONCOLOGY, 2010, 21 : v134 - v136
12345